| Model Number |
EVFXPLUS-29 |
| Medical Device Problem Code |
Material Invagination (1336)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
06/04/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Continuation of d10: product id d-evolutfx-2329 (lot: 0013333885); product type: 0195-heart valves; implant date: n/a ; explant date: n/a medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that during a transcatheter aortic valve implant procedure, a pre-implant balloon aortic valvuloplasty (bav) was completed due to calcification.The delivery catheter system (dcs) was then inserted into the patient and advanced to the aortic annulus.The valve was then deployed and subsequently recaptured due to suboptimal positioning.On the second deployment attempt, the valve was positioned 3-millimeters (mm) from the aortic annulus.However, during deployment an infold was noted so the valve was recaptured into the dcs.In response, the dcs was removed from the patient's body.A new valve and dcs were then utilized to complete the procedure.Per the physician, the patient's calcified anatomy contributed to the infold.No patient complications were reported as a result of this event.
|
| |
|
Search Alerts/Recalls
|